MARTIN MUCCI, a director at $PAYX, sold 97,526 shares of the company on 07-10-2025 for an estimated $14,157,849. We received data on the trade from a recent SEC filing. This was a sale of approximately 17.9% of their shares of this class of stock. Following this trade, they now own 446,917 shares of this class of $PAYX stock.
$PAYX Insider Trading Activity
$PAYX insiders have traded $PAYX stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $PAYX stock by insiders over the last 6 months:
- MARTIN MUCCI sold 97,526 shares for an estimated $14,157,849
- MICHAEL E GIOJA (Sr. Vice President) has made 0 purchases and 2 sales selling 31,653 shares for an estimated $4,893,136.
- JOSEPH M VELLI sold 3,650 shares for an estimated $544,762
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PAYX Hedge Fund Activity
We have seen 698 institutional investors add shares of $PAYX stock to their portfolio, and 691 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SELECT EQUITY GROUP, L.P. added 1,738,372 shares (+99.0%) to their portfolio in Q1 2025, for an estimated $268,196,032
- MORGAN STANLEY removed 1,531,198 shares (-20.4%) from their portfolio in Q1 2025, for an estimated $236,233,227
- CAPITAL INTERNATIONAL INVESTORS removed 1,245,516 shares (-4.6%) from their portfolio in Q1 2025, for an estimated $192,158,208
- CAPITAL WORLD INVESTORS removed 1,204,924 shares (-43.7%) from their portfolio in Q1 2025, for an estimated $185,895,674
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 737,542 shares (+7.3%) to their portfolio in Q1 2025, for an estimated $113,787,979
- NEUBERGER BERMAN GROUP LLC added 657,871 shares (+117.6%) to their portfolio in Q1 2025, for an estimated $101,496,337
- PROFICIO CAPITAL PARTNERS LLC removed 564,710 shares (-99.3%) from their portfolio in Q1 2025, for an estimated $87,123,458
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PAYX Congressional Stock Trading
Members of Congress have traded $PAYX stock 10 times in the past 6 months. Of those trades, 7 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $PAYX stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 6 times. They made 6 purchases worth up to $90,000 on 06/26, 04/09, 02/27, 02/21, 02/09, 02/05 and 0 sales.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/09, 02/21.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 01/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$PAYX Analyst Ratings
Wall Street analysts have issued reports on $PAYX in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Underweight" rating on 06/18/2025
To track analyst ratings and price targets for $PAYX, check out Quiver Quantitative's $PAYX forecast page.
$PAYX Price Targets
Multiple analysts have issued price targets for $PAYX recently. We have seen 10 analysts offer price targets for $PAYX in the last 6 months, with a median target of $153.5.
Here are some recent targets:
- Daniel Jester from BMO Capital set a target price of $160.0 on 07/10/2025
- James Faucette from Morgan Stanley set a target price of $148.0 on 06/27/2025
- David Grossman from Stifel set a target price of $152.0 on 06/26/2025
- Kevin Mcveigh from UBS set a target price of $145.0 on 06/26/2025
- Samad Samana from Jefferies set a target price of $140.0 on 06/26/2025
- Tien-Tsin Huang from JP Morgan set a target price of $148.0 on 06/18/2025
- Ashish Sabadra from RBC Capital set a target price of $165.0 on 06/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.